Anti-Ro/SSA Antibodies Linked to Higher Risk of Interstitial Lung Disease in Systemic Sclerosis Patients
Anti-Ro/SSA antibodies are an independent risk factor for interstitial lung disease in patients with systemic sclerosis, but do not predict disease progression or survival.